This Fortnight in Medicine XXII
About this episode
This episode discusses various studies related to myocardial infarction and treatment strategies, including the risks associated with glucagon-like peptide-1 receptor agonists among veterans with type 2 diabetes.
* Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study * Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction * Andrew’s previous SM post on the subject: How a Meta-Analysis can Mislead—The Story of Complete vs Culprit-only PCI in STEMI And, a bunch of the other studies we discussed. * Complete Revascularization with Multivessel PCI for Myocardial Infarction * FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction * Initial Invasive or Conservative Strategy for Stable Coronary Disease This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
People in this episode
Host: Sensible Medicine Authors and Editors
Topics covered
- glucagon-like peptide-1 receptor agonists
- substance use disorders
- myocardial infarction
- complete revascularization
- PCI strategies
- coronary disease
Keywords
- glucagon-like peptide-1
- substance use disorders
- myocardial infarction
- PCI
- complete revascularization
- coronary disease
- FFR-guided PCI
Mentioned in this episode
Organizations: US veterans
Books & works: How a Meta-Analysis can Mislead—The Story of Complete vs Culprit-only PCI in STEMI
More episodes of Sensible Medicine
- This Fortnight in Medicine XXIV
- This Fortnight in Medicine XXIII
- This Fortnight in Medicine XXI
- Going Beyond "AI in Medicine"
- This Fortnight in Medicine XX
- Alternative Modalities for Breast Cancer Screening
Explore listener stats, chart rankings, contacts and more on the Sensible Medicine podcast page.